FDA clears safety test to screen Tysabri patients

Friday, January 20, 2012 - 16:30 in Health & Medicine

WASHINGTON (AP) -- The Food and Drug Administration says it has approved a new diagnostic test to help identify patients who have an increased risk of developing a rare brain infection while taking Biogen Idec's multiple sclerosis drug Tysabri....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net